Market Command Center
Live
Market Command Center
Johnson & Johnson
Healthcare · Drug Manufacturers - General · NYSE
Price history for JNJ is unavailable — the core-api history endpoint is offline or returned an unexpected payload.
Estimated fair value
233.85
Range
173.67–290.71
Price vs value
14% above
Model support
Value
14% above fair value
confidence low
Estimate momentum
→ stable
Next catalyst
JNJ earnings · 42d
earnings
Volatility
elevated
regime
1M forecast
65% up
median +2.2%
Value tells you the size of the gap; the other cells tell you what could close it — and when. A cheap stock without a catalyst can stay cheap.
Probability higher · median +2.2%
80% range -5.1% to 11.6% · confidence 50%
fresh evidence · uncalibrated
No intelligence items published yet.
Price trades 14% above the fair-value estimate — JNJ screens as moderately overvalued. The 4 models disagree widely (dispersion 48.2%) — treat the range, not the midpoint, as the answer. A valuation gap is not a timing signal and currently has zero ranking weight.
Forward earnings lens
23.5x FY2026 P/E
EPS 11.62+5.4%6 analysts
Shown as context, not blended into fair value, while genuine point-in-time forward-multiple history accumulates.
Where estimates sit vs price 273.41
Total payout (dividends + net buybacks): not shown — dividends are the relevant payout model.
Not meaningful for this company type: excess returns model (financials), path-to-profitability (scenario), p/ocf vs peer reits (ffo proxy).
Cheap or expensive — depending on the yardstick
Entry threshold
below 187.08(fair value 233.85 − 20%)
price is 46% above your threshold
A valuation threshold, not a timing signal — a cheap stock can keep falling. Alerts wire in when the notification substrate lands.
→ Estimates stable (revenue 0.0% · EPS 0.0% · targets 0.0% this month)
Company profile at a glance
Bars are scaled to documented anchors (e.g. 35% operating margin = full bar), not ranked against other companies. Each row stands on its own — there is no hidden total score.
Financials at a glance· latest reported year · 17y of statements
Revenue
$94.2B
+2% per year over the period
Operating margin
27.2%
5y average 25.5%
Free cash flow
$19.7B
20.9% of revenue
Net debt / EBITDA
0.5×
ROE
32.9%
net income ÷ equity
ROIC
19.6%
after-tax operating profit ÷ capital
Dividends paid
$12.4B
latest year
Buybacks
$6.0B
share repurchases, latest year
Where the revenue dollar went · FY2025
What the current price is assuming
These are what the market must believe, not what Previct forecasts. If the priced-in assumptions look impossible, the price is fragile; if they look easy, the bar is low.
What the DCF is made of — present value by year (base case)
Which growth × margin combinations justify today's price
| margin ↓ / growth → | -5% | 0% | 5% | 10% | 15% | 20% | 25% | 30% | 35% | 40% |
|---|---|---|---|---|---|---|---|---|---|---|
| 60% | ||||||||||
| 55% |
Price vs fair value through time
price · fair value (band = bear–bull). Vintages accumulating since 2026-08-13 (recorded at compute time; no historical backfill).
Fair value if assumptions move — discount rate × terminal growth
| discount rate ↓ | g 0% | g 1% | g 2% | g 3% | g 4% |
|---|---|---|---|---|---|
| 6.6% | 161.1 | 175.51 | 196.18 | 228.34 | 285.24 |
| 7.1% | 146.89 | 158.27 | 174.12 | 197.7 | 236.49 |
| 7.6% |
Terminal value is 64% of the total. Solid years are consensus-anchored; lighter years fade to the stable rate.
| 50% |
|---|
| 45% |
|---|
| 40% |
|---|
| 35% |
|---|
| 30% |
|---|
| 25% |
|---|
| 20% |
|---|
| 15% |
|---|
| 10% |
|---|
| 5% |
|---|
| 0% |
|---|
Sage cells are the assumption pairs that make the model value equal today's price (±2%) — none inside these bounds — the price asks for more than this grid allows.
| 134.62 |
| 143.71 |
| 156.05 |
| 173.76 |
| 201.31 |
| 8.1% | 123.94 | 131.27 | 141.01 | 154.56 | 174.73 |
|---|
| 8.6% | 114.56 | 120.52 | 128.29 | 138.83 | 153.95 |
|---|
| 9.1% | 106.27 | 111.15 | 117.4 | 125.7 | 137.26 |
|---|
| 9.6% | 98.9 | 102.91 | 107.99 | 114.59 | 123.56 |
|---|
Cells compare each implied fair value with the current price 273.41: green above it, burgundy below. Outlined cell = base case.